ASCO 2024: Telehealth as effective as in-person care for early palliative treatment in patients with advanced lung cancer
New research reinforces telehealth delivery of palliative care as an effective alternative to in-person visits…
Browsing: ASCO
ASCO 2024: CAR T-cell therapy shows promise in patients with central nervous system lymphoma
A CAR T-cell therapy approved for patients with large B cell lymphoma has produced positive…
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung cancer
Results from a new study demonstrate that consolidation therapy – or treatment given for a…
ASCO 2024: Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-mutated NSCLC
Osimertinib improves progression-free survival in patients with unresectable stage III EGFR-mutated NSCLC that has been…
ASCO 2024: Dual immunotherapy treatment before surgery, rather than after, improves outcomes in melanoma patients
Neoadjuvant immunotherapy given for stage III melanoma, followed by adjuvant therapy only if there is…
ASCO 2024: Lymphadenectomy may not be needed for patients with advanced ovarian cancer
Some people with advanced epithelial ovarian cancer may safely avoid having their lymph nodes removed…
ASCO 2024: Improved progression-free survival in PD-L1-positive hormone receptor-positive, HER2-negative breast cancer
In patients with metastatic hormone receptor (HR)-positive/HER2-negative breast cancer unselected by PD-L1 status, adding the…
ASCO 2024: Drug targeting protein involved in control of immune response produces encouraging results in glioblastoma
A drug that targets a protein involved in regulating the immune response might be promising…
ASCO 2024: Experimental therapy shows promise in pancreatic cancer clinical trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center, USA, reported promising preliminary findings based on…
ASCO 2024: New ‘Armoured’ CAR produces significant responses in patients whose cancers don’t respond to current CAR T cell therapies
While CAR T cell therapy has revolutionised treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many…